NANOMUNNE and ANTICARB workshop
From Safety Assessment to Biomedical Applications'
Brussels, Belgium, 29 November 2011
Carbon nanomaterials hold great potential for a variety of applications, including development of new therapies and diagnosis. There is also a need to determine the risk, limitations and safety of exposure to nanomaterials.
This workshop will address those aspects and present the state-of-the art in the field by bringing together success stories and lessons learnt revealed from research in two FP7 funded projects, ANTICARB and NANOMUNNE, that have worked in this domain for the last 4 years.
More information on the event (355KB)